NAMA
FATE icon

Nikko Asset Management Americas’s Fate Therapeutics FATE Stock Holding History

Nikko Asset Management Americas’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-907,930
Closed -$9.15M – 202
2022
Q4 		$9.15M Sell
907,930
-380,928
-30% -$7.15M 0.13% 87
2022
Q3 		$26.7M Buy
1,288,858
+18,293
+1% +$529K 0.34% 53
2022
Q2 		$29.3M Buy
1,270,565
+7,699
+0.6% +$212K 0.36% 60
2022
Q1 		$46.5M Buy
1,262,866
+20,023
+2% +$775K 0.34% 58
2021
Q4 		$72.2M Sell
1,242,843
-3,727
-0.3% -$211K 0.38% 57
2021
Q3 		$72.3M Buy
1,246,570
+221,051
+22% +$17.3M 0.31% 62
2021
Q2 		$87.3M Buy
1,025,519
+463,924
+83% +$37.4M 0.34% 61
2021
Q1 		$46.3M Buy
561,595
+23,931
+4% +$2.29M 0.23% 83
2020
Q4 		$48.9M Buy
537,664
+49,265
+10% +$3.06M 0.28% 71
2020
Q3 		$19.3M Sell
488,399
-38,912
-7% -$1.36M 0.17% 84
2020
Q2 		$17.1M Sell
527,311
-398,698
-43% -$11.9M 0.22% 68
2020
Q1 		$20.6M Buy
926,009
+106,199
+13% +$2.69M 0.38% 65
2019
Q4 		$16M Sell
819,810
-20,620
-2% -$327K 0.25% 76
2019
Q3 		$13.1M Buy
840,430
+331,589
+65% +$6.36M 0.23% 83
2019
Q2 		$10.3M Buy
+508,841
New +$9.17M 0.2% 86

Other funds holding FATE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Nikko Asset Management Americas's FATE Position: Q1 2023 in Review

Nikko Asset Management Americas sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 907,930 shares — an estimated $9.15M sold.

Nikko Asset Management Americas first reported a position in FATE in Q2 2019 and held it in 15 quarters. The position peaked at $87.3M in Q2 2021. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • Nikko Asset Management Americas reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Nikko Asset Management Americas sold 907,930 Fate Therapeutics shares in Q1 2023, an estimated $9.15M.
  • Nikko Asset Management Americas first reported a position in Fate Therapeutics in Q2 2019 and held it in 15 quarters.
  • Nikko Asset Management Americas's Fate Therapeutics position peaked at $87.3M in Q2 2021.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on Nikko Asset Management Americas's 13F filing for Q1 2023, filed 3 May 2023.